Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2026-01-03 @ 9:06 AM
Study NCT ID:
NCT02351635
Status:
COMPLETED
Last Update Posted:
2019-01-18
First Post:
2015-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS
Sponsor:
Bühlmann Laboratories AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2018-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-27
First Submit QC Date:
None
Study First Post Date:
2015-01-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-17
Last Update Post Date:
2019-01-18
Last Update Post Date Type:
ACTUAL